LIVECAST Markets Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Live News EQUITY FLASH L impact Sep 28, 2026, 03:01 PM UTC

MSGY.O halted: volatility pause

Nasdaq volatility trading pause at 10:58 AM.

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

MSGY.O

Related stories

Vishal Garg Regains Control of Better Home & Finance Board, Names New Directors Vishal Garg, founder of Better Home & Finance Holding Company (NASDAQ: BETR), has regained control of the company's board after shareholders voted to remove incumbent directors. Th M impact | EQUITY | Oct 05, 2026, 07:56 PM UTC Thermo Fisher Scientific Added to JPMorgan's October Growth Selections Thermo Fisher Scientific (TMO) was included in JPMorgan's October growth selections, with its shares rising approximately 1.1% to $662.27. JPMorgan Chase (JPM) identified Thermo Fi M impact | EQUITY | Oct 05, 2026, 07:51 PM UTC Qualcomm Shares Decline 1.34% Amid Huawei Patent Deal Expansion Qualcomm (NASDAQ:QCOM) shares fell approximately 1.34% to $182.40 on Monday, October 5, despite securing a broad, multiyear patent cross-license agreement with Huawei covering 5G, M impact | EQUITY | Oct 05, 2026, 07:48 PM UTC Lam Research Falls as Analyst Lifts Price Target Ahead of Earnings Lam Research (LRCX) declined 0.8% to $344.64 on October 5, despite B. Riley raising its price target ahead of the company's September-quarter earnings report. The analyst maintains M impact | EQUITY | Oct 05, 2026, 07:48 PM UTC Western Digital Jumps 6.4% on Analyst Support for AI Storage Demand Western Digital (WDC) shares surged 6.4% to $441.885, recovering some of Friday's losses. Analysts from Morgan Stanley and Melius Research recommended buying the dip, citing strong M impact | EQUITY | Oct 05, 2026, 07:38 PM UTC AbbVie/Genmab lymphoma drug combo cut progression or death risk by 51% in trial AbbVie Inc and Genmab A/S said their combination treatment for patients newly diagnosed with diffuse large B-cell lymphoma (DLBCL) reduced the risk of disease progression or death M impact | EQUITY | Oct 05, 2026, 07:36 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.